Erin Hahn to Neoplasm Staging
This is a "connection" page, showing publications Erin Hahn has written about Neoplasm Staging.
Connection Strength
0.577
-
Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
Score: 0.129
-
Surveillance Imaging in Patients with Resected Non-Small Cell Lung Cancer: Too Much, Not Enough, or Just Right? Ann Am Thorac Soc. 2016 09; 13(9):1446-7.
Score: 0.127
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.121
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.116
-
Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system. J Manag Care Spec Pharm. 2023 Jun; 29(6):635-646.
Score: 0.051
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.034